arrow
LI Qiang 封面图

LI Qiang (Qiang Li)

School of Basic Medical ScienceDirector
H指数:67
被引数:2.5万

个人简介

Chair of the Department of Pharmacology at Peking University School of Basic Medical Sciences. He returned to PKU in 2024 after nearly a decade as a tenured faculty member at Columbia University, where he rose from Assistant to Associate Professor. The research program is internationally recognized for pioneering work on the role of post-translational modifications (particularly acetylation) of key metabolic regulators like PPARγ in obesity, diabetes, atherosclerosis, and aging. Recent work identified immunoglobulin G (IgG) as a novel aging factor linking immune system changes to metabolic decline.

教育背景

  • 2007.12

    Boston University School of Medicine Ph.D. Biochemistry, Cell and Molecular Biology

  • 2001.12

    Peking University B.S. Biotechnology

工作经历

  • 2025.01 – 至今

    Peking University Aging Research Center

    Director

  • 2024.01 – 至今

    Peking University

    Professor & Chair, Dept. of Pharmacology

  • 2015.01 – 2024.12

    Columbia University

    Associate Professor (with tenure)

荣誉奖项

暂无内容

Implementation of an Australian helpline for low back pain: protocol of a type 2 hybrid effectiveness-implementation trial

实施一个针对澳大利亚下腰痛的热线服务:一项类型2混合有效性-实施研究的方案

2025-12-010
PRE
Phenotyping obesity through a two-dimensional tree structure reveals cardiometabolic heterogeneity

通过二维树结构对肥胖进行表型分析揭示了 cardiometabolic 异质性

2025-09-250
OAAI
The diagnostic value of 18 F-FAPI-04 PET/CT in unresectable hepatocellular carcinoma: a head-to-head comparison with 18 F-FDG PET/CT

18 F-FAPI-04 PET/CT在不切除肝细胞癌中的诊断价值:与18 F-FDG PET/CT的头对头比较

2025-09-220
PRE
Elucidating the heterogeneity of prediabetes through subphenotyping with a two-dimensional tree structure

通过二维树结构对糖尿病前期进行亚表型分析,阐明其异质性

2025-07-020
OAAI
Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials

血压降低与急性脑出血时间相关的影响:INTERACT试验四项研究的合并分析

2025-06-180
PRE
Efficacy and Safety of Electroacupuncture on Insomnia in Parkinson's Disease: A Multicentre, Randomized, Controlled Trial

电针对帕金森病失眠的疗效与安全性:一项多中心、随机对照试验

2025-05-280
PRE
Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)

多靶点酪氨酸激酶抑制剂与信迪利单抗联合肝动脉灌注化疗治疗不可切除肝癌:一项前瞻性、单臂II期试验(DoHAICs研究)

2025-05-010
OA